Sign up to save your podcasts
Or
Share Episode 51 - Verquvo, Opdivo/Cabometyx, & Tepmetko
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 51 - Verquvo, Opdivo/Cabometyx, & Tepmetko
In today’s episodes we'll be discussing the approval of Verquvo for the treatment of heart failure and approval of Tepmetko, a new treatment for metastatic non small cell lung cancer with MET alternations. We'll also be discussing the approval of a new combination therapy for renal cell carcinoma. Don't forget to like, share and subscribe, and ENJOY!
View all episodes
By Ian Parnigoni PharmD.In today’s episodes we'll be discussing the approval of Verquvo for the treatment of heart failure and approval of Tepmetko, a new treatment for metastatic non small cell lung cancer with MET alternations. We'll also be discussing the approval of a new combination therapy for renal cell carcinoma. Don't forget to like, share and subscribe, and ENJOY!